Mounjaro and Fibroids: What the Evidence Says and What to Weigh Up

What the prescribing information actually says about fibroids

Fibroids (benign uterine growths that affect a significant proportion of women of reproductive age) are not mentioned anywhere in the Mounjaro Summary of Product Characteristics as a contraindication or a precaution. The NHS patient information for tirzepatide similarly does not list fibroids among the conditions that prevent use. So if you have searched for a definitive regulatory statement saying the two are incompatible, you will not find one, because it does not exist.

That absence of a warning is reassuring in one sense, but it is not the same as a green light for every individual. What the prescribing information does require is that a qualified clinician reviews your whole health picture, not just whether fibroids appear on an exclusion list. Conditions that matter more directly to prescribing decisions include a history of pancreatitis, certain gastrointestinal disorders, and specific thyroid conditions. A question our prescribers hear most weeks is whether a particular background health condition blocks treatment; the honest answer is usually that it shapes the conversation rather than ending it.

If you want to read the full prescribing detail, including questions about whether tirzepatide has any relationship with fibrosis, the Mounjaro SmPC on the eMC sets out every contraindication and special precaution in one place.

How significant weight loss might indirectly interact with fibroid biology

This is the part of the question that deserves the most careful thought. Fibroids are known to be hormone-sensitive: oestrogen and progesterone both appear to promote their growth, which is why fibroids often shrink after the menopause when oestrogen levels fall. Body fat is itself a source of oestrogen, because fat tissue converts androgens into oestrogen through a process called aromatisation. In people carrying significant excess weight, this can contribute to a relatively higher oestrogen environment.

Meaningful weight loss (the kind that tirzepatide and a reduced-calorie diet together can produce) may therefore gradually reduce that peripheral oestrogen production. Whether this has any clinically meaningful effect on existing fibroids in a given person is genuinely uncertain. There are no randomised trials of GLP-1 medicines specifically in people with fibroids, and predicting how an individual's fibroids will respond to hormonal shifts from weight loss is not something any prescriber can do with precision. For some people, any reduction in oestrogen exposure is welcome; for others, particularly those close to trying to conceive, the picture is more nuanced.

None of this means weight loss is a bad idea if you have fibroids, the broader evidence for treating obesity as a health condition is substantial. It means the conversation with your prescriber about your fibroid history, their current size and any symptoms you experience, is genuinely useful before you start.

Contraception while on tirzepatide, a practical point that matters for many women with fibroids

A significant proportion of women managing fibroids also use hormonal contraception, so this interaction is worth flagging clearly. Tirzepatide slows gastric emptying, which can reduce how reliably oral contraceptives are absorbed during the early weeks of treatment. UK guidance is specific on this: women taking the oral contraceptive pill should use an additional non-oral method (condoms, for example) for the first four weeks of starting Mounjaro and for four weeks after each dose increase. This guidance applies to tirzepatide; the equivalent evidence for semaglutide is less established, as noted by NHS England's weight management guidance.

If you use the contraceptive pill partly to manage fibroid-related symptoms such as heavy periods, unplanned gaps in hormonal cover could matter to you symptomatically as well as contraceptively. Worth raising with whoever manages your fibroid care, not just with the prescribing clinician.

For women on HRT rather than contraception, NHS England similarly advises considering transdermal forms (patches or gels) while taking tirzepatide, for the same absorption reason.

Making the actual decision: what a prescriber weighs up

The realistic choice in front of most people reading this is not "fibroids vs Mounjaro" as an either-or. It is whether to pursue medically supervised weight loss via tirzepatide, with fibroids as part of the clinical context, and how to do that sensibly. If you carry a BMI of 30 or above (or 27 or above alongside a weight-related condition such as high blood pressure or type 2 diabetes) you fall within the licensed eligibility range. Fibroids alone do not push you outside it.

What a prescriber needs is enough information about your fibroid history to make a reasoned judgment: are they currently causing symptoms? Have you had recent imaging? Are you planning a pregnancy in the near future? These questions are part of the clinical assessment, not an obstacle to it. You can read more about how tirzepatide works and what the clinical programme found on our Mounjaro information page, or explore the broader weight-loss treatment options available through our weight loss page.

A note on cost context: if private treatment is on your mind, our Mounjaro pricing page explains what's included in a transparent private prescription service and why headline prices vary across providers.

If you have questions about other health conditions and how they interact with tirzepatide, our pages on fibromyalgia and Mounjaro and Mounjaro and steroids cover related territory. You may also find it useful to read about how Mounjaro can affect hemorrhoids if that is part of your health picture. You can also browse our FAQs or get in touch if you have a question before you start.

When you are ready to take the next step, a free consultation with one of our GPhC-registered prescribers is the right place to bring all of this. They review every application personally, the same day it arrives. Start your free consultation and bring your fibroid history into the conversation, that is exactly what the assessment is for.